When compared to the approved TROP2-targeting ADC, sacituzumab govitecan (Trodelvy), the preliminary ORR of 80% in a heavily pre-treated mTNBC cohort appears numerically higher than the ~ 35% ORR reported in the ASCENT trial, though cross-trial comparisons require caution due to the small initial cohort size of JSKN016
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
No preservatives, no artificial colours, no fillers
Other important ingredients like ashwagandha, curcumin, green tea extract, and gingko biloba extract powder also work in synergy with milk thistle and improve the antioxidant defense of the body
Drugs, which are defined as products used for medical purposes, come under stricter regulation
7A and Fig